ArticlePRiMER (Leawood, Kan.)2025
Association of Primary Payor Source and Glycemic Control Among Patients With Type 2 Diabetes.
Article in PRiMER (Leawood, Kan.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The association between health care payor source and HbA1c in patients with type 2 diabetes (T2D) treated at federally qualified health centers (FQHCs) has been evaluated only in cross-section. FQHCs provide an opportunity to compare the association of glycemic control between populations with or without public or private insurance followed over time. Methods: In this observational study of primary care data, we compared HbA1c values by antecedent insurance status among adults with T2D, before and after adjustment for age, sex, and primary spoken language. Results: Among 9,848 patients evaluated, mean HbA1c differed ( Conclusion: In this study of FQHCs patient data, HbA1c measured after nearly 2 years of payor source observation differed by payor. Measured covariates did not fully explain the differences. Uninsured patients and those with Medicaid had worse HbA1c than those with Medicare or private insurance. These results may be used to inform another study with more available variables to determine what specific factors may mediate the association between payor source and HbA1c.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.